Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen)

Lea Munthe-Fog1, Tina Hummelshøj, Ying Jie Ma

  • 1Department of Clinical Immunology, University of Copenhagen, 2100 Copenhagen, Denmark.

Molecular Immunology
|February 12, 2008
PubMed

Insights

Genetic variations in the FCN3 gene can cause Ficolin-3 deficiency. A specific FCN3 deletion variant was identified, potentially leading to a novel complement deficiency state.

Area of Science:

  • Immunology
  • Genetics

Background:

  • Ficolin-3 (Hakata antigen) is a pattern recognition molecule in the lectin complement pathway.
  • Understanding genetic contributions to Ficolin-3 levels is crucial for comprehending complement system variations.

Purpose of the Study:

  • To investigate if common genetic variations in the FCN3 gene are associated with Ficolin-3 deficiency.
  • To identify and characterize novel FCN3 gene polymorphisms and their functional impact.

Main Methods:

  • FCN3 gene sequencing in 237 healthy Danish Caucasians.
  • ELISA, SDS-PAGE, and western blotting to analyze Ficolin-3 serum profiles and variant function.
  • Production and characterization of recombinant Ficolin-3 variants.

Main Results:

  • Ficolin-3 serum concentration exhibited a 10-fold variation.
  • A FCN3+1637delC deletion polymorphism (allele frequency 0.011) caused a reading frame shift and C-terminal distortion.
  • Heterozygosity for FCN3+1637delC was linked to lower Ficolin-3 concentrations (P=0.025).
  • Recombinant Ficolin-3 characterization indicated that homozygosity for this deletion leads to Ficolin-3 deficiency.

Conclusions:

  • The FCN3+1637delC deletion variant disrupts Ficolin-3's pattern recognition capabilities.
  • Homozygosity for the FCN3+1637delC deletion may cause Ficolin-3 deficiency, representing a novel complement deficiency state.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...